Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ENSG00000119950.21 | MAX interactor 1, dimerization protein | |
ENSG00000136997.21 | MYC proto-oncogene, bHLH transcription factor | |
ENSG00000134323.12 | MYCN proto-oncogene, bHLH transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MXI1 | hg38_v1_chr10_+_110207587_110207684 | -0.59 | 4.0e-04 | Click! |
MYC | hg38_v1_chr8_+_127735597_127735659 | 0.41 | 2.1e-02 | Click! |
MYCN | hg38_v1_chr2_+_15940537_15940566 | -0.28 | 1.2e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 31.6 | GO:0042254 | ribosome biogenesis(GO:0042254) |
1.2 | 17.7 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
2.4 | 14.2 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.4 | 14.0 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.4 | 13.4 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.3 | 13.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.8 | 12.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 12.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 12.3 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.6 | 11.6 | GO:0006069 | ethanol oxidation(GO:0006069) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 60.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 52.6 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 29.4 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 27.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.9 | 20.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 20.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 18.6 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 17.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.5 | 16.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 15.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 87.9 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 33.3 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 29.8 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 25.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
2.5 | 22.7 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.7 | 22.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 13.7 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 13.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 12.6 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.4 | 11.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 62.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 21.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 17.0 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 14.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.5 | 10.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 10.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 10.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 8.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 8.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 7.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 24.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 23.5 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.2 | 20.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.8 | 19.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 17.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 14.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 14.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 13.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 13.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 11.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |